secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2022-05-23T23:59:59+00:00
Accession:  0001193125-22-157432
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn settles former CMO suit, grants 8.3M shares & 7M warrants; board member resigns
--------------------------------------------------------------------------------

- Settlement with former CMO Richard Pestell resolves breach-of-contract lawsuit; CytoDyn relinquishes 8,342,000 shares and removes transfer restrictions.
- Company grants Pestell three-year warrants to purchase 7,000,000 shares at $0.37 per share, plus registration rights.
- Parties dismiss lawsuit and release all claims; intangible assets from ProstaGene transaction transferred to Pestell.
- Board member Jordan G. Naydenov resigned effective May 17, 2022, with no reason given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000119312522157432/0001193125-22-157432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000119312522157432/d306532d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-157432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer